Researchers identify blood-based biomarkers that could help personalize treatment for autoimmune diabetes

AI Summary

Researchers at Bar-Ilan University's Azrieli Faculty of Medicine identified blood biomarkers that predicted which mice responded to an experimental combination treatment for latent autoimmune diabetes in adults. The treatment normalized blood sugar in about one-third of treated mice and stimulated regeneration of insulin-producing pancreatic cells.

Researchers at Bar-Ilan University's Azrieli Faculty of Medicine have identified blood biomarkers that accurately predict which mice would respond to an experimental combination therapy for latent autoimmune diabetes in adults (LADA), a form of autoimmune diabetes that is frequently mistaken for type 2 diabetes. The findings, published in MedComm, also show that the treatment restored normal blood sugar levels in about one-third of treated mice and stimulated the regeneration of insulin-producing cells in the pancreas.